Larry Nishnick > DLA Piper LLP (US) > San Diego (Golden Triangle), United States > Lawyer Profile

DLA Piper LLP (US)
4365 EXECUTIVE DRIVE
SUITE 1100
SAN DIEGO, CA 92121-2133
United States
Larry Nishnick photo

Work Department

Corporate; Media, Sport and Entertainment; Technology; Life Sciences

Position

Partner

Career

Larry Nishnick advises both private emerging growth companies and established, public company clients throughout a broad range of industries, including technology, software, life sciences and healthcare, sports, media, entertainment, consumer products and retail, consumer finance, cleantech and the internet of things. Larry also advises private equity, venture capitalists and angel investors in connection with their investments.

Larry advises clients from the initial formation and early-stage fundraisings through later-stage venture capital and private equity financings to IPOs and follow-on offerings, PIPEs and debt financings. Larry has extensive experience in mergers and acquisitions, joint ventures, partnerships, collaborations and other strategic transactions. Larry’s practice also includes SEC disclosure and reporting requirements, including 1933 Act and 1934 Act disclosure and the reporting requirements of NYSE, NASDAQ and AMEX.

 

Education

J.D., University of San Diego School of Law; B.A., Washington & Jefferson College

Lawyer Rankings

United States > Industry focus > Healthcare: life sciences

Co-heads of DLA Piper LLP (US)‘s practice, San Diego-based Lisa Haile and Matthew Holian in Boston, specialize in patentability and licensing strategies, and product liability and mass tort, respectively. Recent highlights include obtaining issuance of multiple patents for Aegis Therapeutics’ key product areas and assisting Pfizer and Bristol-Myers Squibb (BMS) with multidistrict and state court litigation concerning alleged defects of the clients’ blockbuster anticoagulant medication Eliquis. New York-based litigator Loren Brown has been acting for Medtronic and Covidien in product liability litigation related to complications allegedly caused by some of Covidien’s implantable hernia mesh products. San Diego’s Larry Nishnick and Austin’s Aaron Fountain are names to note for corporate investment and patent litigation respectively.